Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation

Background Activation of the immune system is suggested to prevent transplant tolerance and to promote the development of bronchiolitis obliterans syndrome (BOS). The innate immune system is activated by the interaction of pathogen-associated molecular patterns of microorganisms with Toll-like recep...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of heart and lung transplantation Vol. 29; no. 6; pp. 665 - 671
Main Authors Kastelijn, Elisabeth A., MD, van Moorsel, Coline H.M., PhD, Rijkers, Ger T., PhD, Ruven, Henk J.T., PhD, Karthaus, Vincent, MSc, Kwakkel-van Erp, Johanna M., MD, van de Graaf, E.A., MD, PhD, Zanen, Pieter, MD, van Kessel, Diana A., MD, Grutters, Jan C., MD, PhD, van den Bosch, Jules M.M., MD, PhD
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.06.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Activation of the immune system is suggested to prevent transplant tolerance and to promote the development of bronchiolitis obliterans syndrome (BOS). The innate immune system is activated by the interaction of pathogen-associated molecular patterns of microorganisms with Toll-like receptors (TLRs). Activation of innate immunity via TLRs was shown to be a barrier to the induction of transplantation tolerance after lung transplantation. We hypothesized that polymorphisms in 10 genes coding for TLR1 to TLR10 might contribute to an altered immune response and the subsequent development of BOS. Methods DNA was collected from 110 lung transplant recipients. Twenty patients developed BOS. The control group comprised 422 individuals. Sixty-four single-nucleotide polymorphisms (SNPs) in 10 genes coding for TLR1 to TLR10 were genotyped. Results The genotype distribution of TLR2 (rs1898830 and rs7656411), TLR4 (rs1927911) and TLR9 (rs352162 and rs187084) was significantly different between BOSpos patients and BOSneg patients and controls. The BOSpos group had significantly more patients with 3 or 4 of these risk alleles compared with the BOSneg and control groups. Conclusions Polymorphisms in TLR2, TLR4 and TLR9 that recognize bacterial and viral pathogens are associated with BOS after lung transplantation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1053-2498
1557-3117
DOI:10.1016/j.healun.2009.12.013